CD8A and Encephalopathy: Key laboratory findings included significantly lower levels of interferon-gamma (IFN-γ) (P < .001), tumor necrosis factor-alpha (TNF-α) (P < .001), and a decreased CD4+/CD8 + ratio (P = .001) compared to the non-encephalopathy group.